Moving Forward Fast with FAST-Forward.

Published on May 13, 2021in Clinical Oncology3.113
· DOI :10.1016/J.CLON.2021.04.007
P Lewis1
Estimated H-index: 1
(University Hospitals Bristol NHS Foundation Trust),
A.M. Brunt12
Estimated H-index: 12
(Keele University)
+ 3 AuthorsT. Roques1
Estimated H-index: 1
(Royal College of Radiologists)
📖 Papers frequently viewed together
8 Citations
#1K. Spencer (University of Leeds)H-Index: 7
#2Christopher M. Jones (University of Leeds)H-Index: 25
Last. Eva J.A. Morris (University of Oxford)H-Index: 3
view all 13 authors...
Summary Background The indirect impact of the COVID-19 pandemic on cancer outcomes is of increasing concern. However, the extent to which key treatment modalities have been affected is unclear. We aimed to assess the impact of the pandemic on radiotherapy activity in England. Methods In this population-based study, data relating to all radiotherapy delivered for cancer in the English NHS, between Feb 4, 2019, and June 28, 2020, were extracted from the National Radiotherapy Dataset. Changes in me...
4 CitationsSource
#1A.M. Brunt (Keele University)H-Index: 12
#2Joanne S Haviland (ICR: Institute of Cancer Research)H-Index: 27
Last. John R Yarnold (The Royal Marsden NHS Foundation Trust)H-Index: 1
view all 46 authors...
Summary Background We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we present 5-year results of the FAST-Forward trial. Methods FAST-Forward is a multicentre, phase 3, randomised, non-inferiority trial done at 97 hospitals (47 radiotherapy centres and 50 referring h...
103 CitationsSource
#1Richard M. Rosenfeld (SUNY Downstate Medical Center)H-Index: 68
Last. Maureen D. CorriganH-Index: 12
view all 3 authors...
Clinical consensus statements reflect opinions drafted by content experts for which consensus is sought using explicit methodology to identify areas of agreement and disagreement. In contrast to clinical practice guidelines, which are based primarily on high-level evidence, clinical consensus statements are more applicable to situations where evidence is limited or lacking, yet there are still opportunities to reduce uncertainty and improve quality of care. This manual describes methodology used...
25 CitationsSource
#1Joanne S Haviland (University of Southampton)H-Index: 27
#2J Roger Owen (Cheltenham General Hospital)H-Index: 2
Last. John Yarnold (ICR: Institute of Cancer Research)H-Index: 71
view all 16 authors...
Summary Background 5-year results of the UK Standardisation of Breast Radiotherapy (START) trials suggested that lower total doses of radiotherapy delivered in fewer, larger doses (fractions) are at least as safe and effective as the historical standard regimen (50 Gy in 25 fractions) for women after primary surgery for early breast cancer. In this prespecified analysis, we report the 10-year follow-up of the START trials testing 13 fraction and 15 fraction regimens. Methods From 1999 to 2002, w...
664 CitationsSource
Cited By1
#1A.M. Brunt (Keele University)H-Index: 12
#1A.M. Brunt (ICR: Institute of Cancer Research)H-Index: 2
Last. John YarnoldH-Index: 71
view all 7 authors...
Abstract Introduction The phase 3 FAST-Forward trial reported outcomes for 26 and 27 Gy schedules delivered in 5 fractions over 1 week versus 40 Gy in 15 fractions over 3 weeks in 4000 patients. We discuss concerns raised by the radiotherapy community in relation to implementing this schedule. Ipsilateral Breast Tumour Relapse (IBTR) Published estimated 5-year IBTR with 95% CI after 40 Gy in 15 fractions was 2.1% (95% CI 1.4–3.1), 1.7% (1.2–1.6) after 27 Gy and 1.4% (0.2–2.2) after 26 Gy, emphat...